Transaction · 0001437749-26-018628

Krempa David

Krempa David, CBO, reported an open-market or private sale at Eton Pharmaceuticals, Inc. involving 32963.000000 shares for an estimated $1095057.23. Reported holdings after the transaction were 35083.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCBO
ETONEton Pharmaceuticals, Inc.
Trade date
May 22, 2026
Filing date
May 27, 2026
View on SEC Insider profile
Estimated value-$1.09MShares × reported price
Shares traded32.9k$33.22 per share
Holdings after35.0kDirect
% of reported position traded48.44%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 68,046 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ETON price since this filing

Daily closing prices, with the filing date and available return windows
ETON · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -27.1%1w ago -6.6%1d ago +8.0%
Returns since7d -14.8%30d +10.2%90d +94.5%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-018628
Common Stock
Transaction date
May 22, 2026
Filed May 27, 2026, 10:28 PM · 5d delay
Shares
32,963 sh
$33.22 per share
Estimated value
-$1.09M
Computed from shares × price
Holdings after
35,083 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction Large Sale
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at…

  2. F2

    The shares were sold in multiple trades at prices ranging from $33.68 to $34.66. The price reported above reflects the weighted average sales price.

  3. F3

    The shares were sold in multiple trades at prices ranging from $31.27 to $32.16. The price reported above reflects the weighted average sales price.

  4. F4

    The shares subject to the option vested in 48 equal monthly installments from the date of grant (3-12-2020) until fully vested.

  5. F5

    The shares were sold in multiple trades at prices ranging from $31.25 to $31.825. The price reported above reflects the weighted average sales price.

  6. F6

    The shares subject to the option vested annually from the date of grant (11-10-2017) in four equal installments.

  7. F7

    The shares were sold in multiple trades at prices ranging from $32.67 to $33.65. The price reported above reflects the weighted average sales price.

  8. F8

    The shares subject to option vested annually from the date of grant (8-7-2017) in four equal installments.

Original filing · 0001437749-26-018628
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ETON